Is the primary antiphospholipid syndrome a forerunner of SLE?;Primer antifoszfolipid szindróma: A szisztémás lupus erythematosus elofutára?

Orvosi Hetilap

Volumn 146, Issue 5, 2005, Pages 203-207

  Tarr, Tünde ^a   Muzes, Györgyi ^d   Pitlik, Ervin ^d   Lakos, Gabriella ^b   Csépány, Tünde ^c   Soltész, Pál ^b   Zeher, Margit ^a   Szegedi, Gyula ^a,b   Kiss, Emese ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Intenzív Terápiás Részleg ^*  (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Antiphospholipid syndrome; Cerebrovascular event; Systemic lupus erythematosus; Thrombosis

Indexed keywords

ANTINUCLEAR ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CEREBROVASCULAR ACCIDENT; DISEASE COURSE; HEMATOLOGIC DISEASE; HUMAN; NEPHRITIS; POLYARTHRITIS; PROGNOSIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ADULT; BLOOD; FEMALE; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED;

EID: 15744391644     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Alegre, V. A., Gastineau, D. A., Winkelmann, R. K.: Skin lesions associated with circulating lupus anticoagulant. Br. J. Dermatol., 1989, 120, 419-429.
2. Bick, R. L.: Antiphospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management. Int. J. Hematol., 1997, 65, 193-213.
3. Bick, R. L., Baker, W. F.: Antiphospholipid syndrome and thrombosis. Seminars Thromb. Haemost., 1999, 25, 333-350.
4. Brandt, J. T., Triplett, D. A., Alving, B. és mtsa: Criteria for the diagnosis of lupus anticoagulants: an update. Thromb. Haemost., 1995, 74, 1185-1190.
5. Carbone, J., Orera, M., Rodriguez-Pérez, C. és mtsai: Immunological abnormalities in primary APS evolving into SLE: 6 years follow-up in woman with repeated pregnancy loss. Lupus, 1999, 8, 274-278.
6. Cervera, R., Asherson, R. A.: Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology, 2003, 207, 5-11.
7. De Bandt, M., Benali, K., Guillevin, L. és mtsai: Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestation of antiphospholipid syndrome. A prospective study. J. Reumatol., 1999, 26, 91-96.
8. Derksen, R., Gmeling-Meijling, F. de Groot, P. G.: Case Report Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus, 1996, 5, 77-80.
9. Derksen, R. H., de Groot, P. G., Kappelle, L. J.: Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome. Neurology, 2003, 61, 111-114.
10. Fetoni, V., Grisou, M., Salmaggi, A. és mtsai: Clinical and neuroradiological aspects of Sneddon's syndrome and primary antiphospholipid antibody syndrome. A follow-up study. Neurol. Sci., 2000, 21, 157-164.
11. George, J., Harats, D., Gilburd, B. és mtsai: Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. Lupus, 1999, 8, 220-226.
12. Gharavi, A. E., Harris, E. N., Asherson, R. A.: Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann. Rheum. Dis., 1987, 46, 1-6.
13. Haris, E. N., Gharavi, A. E., Boey, M. L. és mtsai: Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet, 1983, 2, 1211-1213.
14. Harris, E. N.: The Second International Anticardiolipin Standardisation Workshop/The Kingston Antiphospholipid Antibody Study (KAPS) group. Am. J. Pathol., 1990, 94, 476-484.
15. Hochberg, M.: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 1997, 40, 1725-1734.
16. Hughes, G. R., Harris, E. N., Ghravi, A. E.: The anticardiolipin syndrome, J. Reumatol., 1986, 13, 486-489.
17. Krnic-Barrie, S., O'Connor, C. R., Looney, S. W. és mtsai: A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch. Intern. Med., 1997, 157, 2101-2108.
18. Lakos, G., Kiss, E., Regeczy, N. és mtsai: Antiprothrombin and antiannexin V antibodies imply the risk of thrombosis in patients with systemic autoimmune diseases. J. Rheumatol., 2000, 27, 924-929.
19. Lakos, G., Kiss, E., Regeczy, N. és mtsai: Isotype distribution and clinical relevance of anti-beta2 glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. Clin. Exp. Immunol., 1999, 117, 574-579.
20. Lakos G., Kiss E., Zeher M. és mtsai: Új ELISA módszer beta2-glycoprotein I elleni autoantitestek kimutatá sára. Klin. Kisérl. Lab. Med. 1998, 25, 73-77.
21. Love, P. E., Santaro, S. A.: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann. Intern. Med., 1990, 112, 682-698.
22. Merill, J. T.: The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis. Curr. Rheumatol. Rep., 2003, 5, 401-406.
23. Mujic, F., Cuadrado, M. J., Lloyd, M. és mtsai: Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J. Rheumatol., 1995, 22, 1589-1598.
24. Munoz-Rodriguez, F. J., Font, J., Cervere, R. és mtsai: Clinical and follow-up of 100 patients with the antiphospholipid syndrome. Arth. Rheumatol., 1999, 29, 182-190.
25. Nochy, D., Daugas, E., Hill, G. és mtsa: Anti-phospholipid syndome nephropathy. Ann. Med. Interne (Paris), 2003, 154, 51-58.
26. Rumpl, E., Rumpl, H.: Recurrent transient global amnesia in a case with cerebrovascular lesions and livedo reticularis (Sneddon Syndrome). J. Neurol., 1979, 221, 127-131.
27. Skarsvag, S., Hansen, K. E., Moen, T. és mtsai: Distribution of HLA class II alleles in autoantibody subsets among Norwegian patients with systemic lupus erythematosus. Scand. J. Immunol., 1995, 42, 564-571.
28. Soltesz, P., Veres, K., Lakos, G. és mtsai: Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients. Lupus, 2003, 12, 302-307.
29. Wilson, W. A., Gharavi, A. E., Koike, T. és mtsai: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Am. Coll. Rheumatol., 1999, 42, 1309-1311.